Status:
COMPLETED
Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV
Lead Sponsor:
University of Washington
Collaborating Sponsors:
Kenya Medical Research Institute
University of California, San Francisco
Conditions:
HIV Infections
Acquired Immunodeficiency Syndrome
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Early accurate diagnosis is one of the first crucial steps in care for infants born to HIV-infected mothers. Early initiation of antiretroviral therapy (ART) relies upon early diagnosis and results in...
Eligibility Criteria
Inclusion
- age at least 18 years
- report ability to read SMS
- ≥ 28 weeks gestation or delivery at study clinic on day of enrollment
- HIV positive women enrolled in the PMTCT program
- have access to a mobile phone (personal or partner's if HIV serostatus disclosed to partner)
- willing to receive SMS messages from the study
- planning to remain in the study area (Nyanza province) for the duration of the study
Exclusion
- age less than 18 years old
- women who share phones with partners but HIV status not disclosed to partners
- intention to deliver at a non-study hospital
Key Trial Info
Start Date :
April 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2013
Estimated Enrollment :
388 Patients enrolled
Trial Details
Trial ID
NCT01433185
Start Date
April 1 2012
End Date
July 1 2013
Last Update
January 21 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kenya Medical Research Institute, Family AIDS Care and Education Services
Kisumu, Nyanza, Kenya